Wilmington, DE, Oct. 19, 2023 Enovis™ Corporation today announced its intention to offer, subject to market conditions and other factors, $400 million aggregate principal amount of.
Wilmington, DE, Oct. 19, 2023 Enovis™ Corporation today released the following preliminary information about its performance for the third quarter ended September 29, 2023. Revenues.
Creating a high-growth, global reconstruction leader with ~$1 billion in annual revenueAttractive margin profile and meaningful synergies expected to increase profitability Wilmington, DE,.
Wilmington, DE, July 06, 2023 Enovis™ Corporation , an innovation-driven, medical technology growth company, announced today that it has been recognized as one of America’s Greatest.
Wilmington, DE, June 28, 2023 (GLOBE NEWSWIRE) Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it closed the acquisition of Novastep®, a subsidiary of Amplitude Surgical .